Laurion Capital Management LP Revolution Medicines, Inc. Transaction History
Laurion Capital Management LP
- $5.23 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
302Shares Held
182MCall Options Held
654KPut Options Held
944K-
Vanguard Group Inc Valley Forge, PA16.6MShares$661 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$539 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$534 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$469 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$406 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.49B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...